Latest Finasteride Stories

HOUSTON, April 28 /PRNewswire/ -- SeqWright Inc., a CLIA certified and GLP compliant provider of custom genomic and molecular biology services, announced today its entry into the genetically-targeted therapy field through its partnership with PharmaGenoma. SeqWright will be the exclusive genetic testing provider for PharmaGenoma's HairDX test which evaluates patient responsiveness to the common hair loss treatment, Finasteride. Finasteride is a commonly prescribed medication for the...

DENVER, April 27 /PRNewswire-USNewswire/ -- Phase II data presented at the annual meeting of the American Urology Association (AUA) indicate that men suffering from an enlarged prostate may benefit from BOTOX(R) injections. The two-stage, multi-center, double-blind, randomized study showed that two different dose levels of Botulinium Neurotoxin Type A (BOTOX) injected into the prostate was both safe and efficacious for the management of benign prostatic hyperplasia (BPH), a common...

Important medical groups are recommending that healthy men use regular tests and should think about taking a drug that may prevent future prostate cancer.They do not outright say that adults should take the drug finasteride, generically called Proscar. Like all prescription drugs, there are both benefits and risks and it can be confusing.The drug reduces the chance contracting prostate cancer by 25 percent. "If a man is interested enough in being screened, then at least he ought to have...

Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), today unveiled the next generation of its genetic screening test for male pattern baldness. The HairDX test is available immediately thru qualified physicians' offices. Using the HairDX test, a physician can tell a man who tests positive for the high risk genetic variant that he has approximately a 70% chance of going bald. Similarly, a physician can tell a man who tests...

Use of a class of medications for treating an enlarged prostate is not associated with an increased hip fracture risk, U.S. researchers said. Benign prostatic hyperplasia, or an enlarged prostate, is a common condition that affects some 8 million U.S. men and treatment includes surgical procedures, minimally invasive procedures and medications. Most often the first-line therapy is pharmacological, using either alpha-blockers, or 5-alpha reductase inhibitors such as finasteride or...

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce two separate presentations of new data by independent clinical investigators involved in U.S. clinical trials of NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The first presentation was at the annual meeting of the Northeastern Section of the American Urological Association in Santa Ana Pueblo, NM; the second at the annual meeting of the South Central Section of the American Urological...

PALO ALTO, Calif. _ Watch out, Rogaine. Stanford University researchers have pinpointed a molecule that triggers hair follicle growth in mice, a treatment that one day could eventually mean some shaggy dos, or at least a few more strands, for humans who have experienced hair loss. The report, published Thursday in the Journal of Genes and Development, focuses on a molecule called laminin-511. The molecule acts like an operator, transferring messages, or proteins, between the outer and...

By Gina Kolata For the first time, leading prostate cancer specialists say they have a drug that can significantly cut men's risk of developing the disease, dropping the incidence by 30 percent. But the discovery, arising from a new analysis of a large federal study, comes with a debate: Should men take the drug? Prostate cancer is unlike any other because it is relatively slow- growing, and while it can kill, it often is not lethal. In fact, most leading specialists say, a major problem is...

By GINA KOLATA By Gina Kolata The New York Times For the first time, leading specialists in prostate cancer say, they have a drug that can significantly cut men's risk of developing the disease, dropping the incidence by 30 percent. But the discovery, arising from a new analysis of a large federal study, comes with a debate: Should men take the drug? Prostate cancer is unlike any other because it is relatively slow- growing and, while it can kill, it often is not lethal. Most leading...

Diet high in vegetables, low in fat, plus moderate alcohol may reduce the risk of BPHSEATTLE "“ Men who eat a diet low in fat and red meat but high in vegetables and lean protein and who drink alcohol in moderation may not just be doing their hearts a favor. A new study shows that such a heart-healthy diet may also be good for the prostate. Specifically, such a diet significantly decreases the risk of symptomatic benign prostatic hyperplasia, or BPH. The bothersome condition is associated...